{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:46:49Z","timestamp":1780580809714,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Child and Adolescent Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.chc.2018.07.005","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T02:07:17Z","timestamp":1535076437000},"page":"79-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Anti-N-Methyl d-Aspartate Receptor Encephalitis and Electroconvulsive Therapy"],"prefix":"10.1016","volume":"28","author":[{"given":"Yasas Chandra","family":"Tanguturi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson Witters","family":"Cundiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.chc.2018.07.005_bib1","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.chc.2018.07.005_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.chc.2018.07.005_bib3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.chc.2018.07.005_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents","volume":"66","author":"Florance","year":"2009","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.chc.2018.07.005_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.chc.2018.07.005_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jneuroim.2010.09.012","article-title":"Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis","volume":"231","author":"Wandinger","year":"2011","journal-title":"J\u00a0Neuroimmunol"},{"issue":"6","key":"10.1016\/j.chc.2018.07.005_bib7","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.chc.2018.07.005_bib8","first-page":"225","article-title":"Electroconvulsive therapy in anti-N-Methyl-D-aspartate receptor encephalitis: a case report and review of the literature","volume":"32","author":"Coffey","year":"2016","journal-title":"J\u00a0ECT"},{"issue":"6","key":"10.1016\/j.chc.2018.07.005_bib9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/MOP.0b013e3283402d2f","article-title":"Update on anti-N-methyl-D-aspartate receptor encephalitis in children and adolescents","volume":"22","author":"Florance-Ryan","year":"2010","journal-title":"Curr Opin Pediatr"},{"issue":"6","key":"10.1016\/j.chc.2018.07.005_bib10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psym.2013.03.002","article-title":"Anti-NMDA receptor encephalitis in a 14-year-old female presenting as malignant catatonia: medical and psychiatric approach to treatment","volume":"54","author":"Wilson","year":"2013","journal-title":"Psychosomatics"},{"key":"10.1016\/j.chc.2018.07.005_bib11","series-title":"Diagnostic and statistical manual of mental disorders; revised (DSM-III-R)","year":"1987"},{"key":"10.1016\/j.chc.2018.07.005_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/NDT.S147897","article-title":"Systematic review of catatonia treatment","volume":"14","author":"Pelzer","year":"2018","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"10.1016\/j.chc.2018.07.005_bib13","article-title":"Catatonia update","volume":"19","author":"Brar","year":"2017","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.chc.2018.07.005_bib14","series-title":"Diagnostic and statistical manual of mental disorders, text revision (DSM-IV-TR)","year":"2000"},{"key":"10.1016\/j.chc.2018.07.005_bib15","series-title":"Diagnostic and statistical manual of mental disorders (DSM-5\u00ae)","year":"2013"},{"key":"10.1016\/j.chc.2018.07.005_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mehy.2018.02.009","article-title":"Molecular hypotheses to explain the shared pathways and underlying pathobiological causes in catatonia and in catatonic presentations in neuropsychiatric disorders","volume":"113","author":"Peter-Ross","year":"2018","journal-title":"Med Hypotheses"},{"issue":"2","key":"10.1016\/j.chc.2018.07.005_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1176\/ps.26.2.91","article-title":"Catatonia: diagnosis and management","volume":"26","author":"Morrison","year":"1975","journal-title":"Psychiatr Serv"},{"issue":"5","key":"10.1016\/j.chc.2018.07.005_bib18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1176\/ajp.154.5.595","article-title":"Half a century of ECT use in young people","volume":"154","author":"Rey","year":"1997","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.1016\/j.chc.2018.07.005_bib19","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/archgenpsychiatry.2009.141","article-title":"The catatonia syndrome: forgotten but not gone","volume":"66","author":"Fink","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1016\/j.chc.2018.07.005_bib20","first-page":"236","article-title":"The prevalence of electroconvulsive therapy use since 1973: a meta-analysis","volume":"32","author":"Lesage","year":"2016","journal-title":"J\u00a0ECT"},{"issue":"10","key":"10.1016\/j.chc.2018.07.005_bib21","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1212\/WNL.0b013e3181f11dc1","article-title":"Pearls & oysters: electroconvulsive therapy in anti-NMDA receptor encephalitis","volume":"75","author":"Braakman","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.chc.2018.07.005_bib22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1440-1819.2012.02324.x","article-title":"Electroconvulsive therapy can improve psychotic symptoms in anti-NMDA-receptor encephalitis","volume":"66","author":"Matsumoto","year":"2012","journal-title":"Psychiatry Clin Neurosci"},{"issue":"2","key":"10.1016\/j.chc.2018.07.005_bib23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1176\/appi.neuropsych.11070151","article-title":"A\u00a0multidisciplinary approach to the treatment of anti-NMDA-receptor antibody encephalitis: a case and review of the literature","volume":"24","author":"Mann","year":"2012","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"issue":"5","key":"10.1016\/j.chc.2018.07.005_bib24","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/PRA.0000000000000100","article-title":"A\u00a0case of anti-NMDA receptor encephalitis treated with ECT","volume":"21","author":"Jones","year":"2015","journal-title":"J\u00a0Psychiatr Pract"},{"issue":"3","key":"10.1016\/j.chc.2018.07.005_bib25","first-page":"e13","article-title":"Successful treatment of refractory dyskinesia secondary to anti-N-methyl-D-aspartate receptor encephalitis with electroconvulsive therapy","volume":"32","author":"Sunwoo","year":"2016","journal-title":"J\u00a0ECT"},{"issue":"4","key":"10.1016\/j.chc.2018.07.005_bib26","first-page":"267","article-title":"Electroconvulsive therapy in a pediatric patient with malignant catatonia and paraneoplastic limbic encephalitis","volume":"22","author":"Lee","year":"2006","journal-title":"J\u00a0ECT"},{"issue":"3","key":"10.1016\/j.chc.2018.07.005_bib27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pediatrneurol.2004.10.004","article-title":"Electroconvulsive therapy for malignant catatonia in childhood","volume":"32","author":"Slooter","year":"2005","journal-title":"Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.chc.2018.07.005_bib28","first-page":"e44","article-title":"Electroconvulsive therapy as an intervention for autoimmune neuropsychiatric disease","volume":"33","author":"Chamberlin","year":"2017","journal-title":"J\u00a0ECT"},{"issue":"3","key":"10.1016\/j.chc.2018.07.005_bib29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.9758\/cpn.2017.15.3.210","article-title":"How electroconvulsive therapy works?: understanding the neurobiological mechanisms","volume":"15","author":"Singh","year":"2017","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"2","key":"10.1016\/j.chc.2018.07.005_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/0269881113507639","article-title":"Pivotal role of tissue plasminogen activator in the mechanism of action of electroconvulsive therapy","volume":"28","author":"Hoirisch-Clapauch","year":"2014","journal-title":"J\u00a0Psychopharmacol"},{"issue":"1\u20132","key":"10.1016\/j.chc.2018.07.005_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0169-328X(98)00211-3","article-title":"Differential effects of electroconvulsive shock on the glutamate receptor mRNAs for NR2A, NR2B and mGluR5b","volume":"61","author":"Watkins","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"10.1016\/j.chc.2018.07.005_bib32","first-page":"87","article-title":"Searching for the mechanism (s) of ECT's therapeutic effect","volume":"30","author":"McCall","year":"2014","journal-title":"J\u00a0ECT"},{"issue":"2","key":"10.1016\/j.chc.2018.07.005_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0447.1996.tb09814.x","article-title":"Catatonia. I. Rating scale and standardized examination","volume":"93","author":"Bush","year":"1996","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"10.1016\/j.chc.2018.07.005_bib34","first-page":"223","article-title":"Refractory catatonia due to N-methyl-D-aspartate receptor encephalitis responsive to electroconvulsive therapy: the clinical use of the clock drawing test","volume":"33","author":"Medina","year":"2017","journal-title":"J\u00a0ECT"},{"issue":"4","key":"10.1016\/j.chc.2018.07.005_bib35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.chc.2018.07.005_bib36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/NNR.0000000000000192","article-title":"Validity of the Montreal cognitive assessment screener in adolescents and young adults with and without congenital heart disease","volume":"66","author":"Pike","year":"2017","journal-title":"Nurs Res"},{"key":"10.1016\/j.chc.2018.07.005_bib37","article-title":"A\u00a0causality algorithm to guide diagnosis and treatment of catatonia due to autoimmune conditions in children and adolescents","author":"Ferrafiat","year":"2017","journal-title":"Schizophr Res"},{"issue":"5","key":"10.1016\/j.chc.2018.07.005_bib38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0006-3223(96)00378-2","article-title":"Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia","volume":"42","author":"Petrides","year":"1997","journal-title":"Biol Psychiatry"},{"issue":"7","key":"10.1016\/j.chc.2018.07.005_bib39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1532-5415.1985.tb05460.x","article-title":"Univariate and multivariate analyses of the mental status examination","volume":"33","author":"Klein","year":"1985","journal-title":"J\u00a0Am Geriatr Soc"}],"container-title":["Child and Adolescent Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056499318306576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056499318306576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T22:46:50Z","timestamp":1761000410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056499318306576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1056499318306576"],"URL":"https:\/\/doi.org\/10.1016\/j.chc.2018.07.005","relation":{},"ISSN":["1056-4993"],"issn-type":[{"value":"1056-4993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-N-Methyl d-Aspartate Receptor Encephalitis and Electroconvulsive Therapy","name":"articletitle","label":"Article Title"},{"value":"Child and Adolescent Psychiatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chc.2018.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}